Transcription of DATA SHEET 1. PRODUCT NAME (strength …
{{id}} {{{paragraph}}}
171211 Xarelto DS Page 1 of 35 DATA SHEET 1. PRODUCT NAME (strength pharmaceutical form) Xarelto 10 mg film-coated tablets Xarelto 15 mg film-coated tablets Xarelto 20 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Rivaroxaban is an odourless, non-hygroscopic white to yellowish powder. Rivaroxaban is practically insoluble in water and aqueous media in the pH range 1 to 9. An amount of approximately 5 - 7 mg/L rivaroxaban is pH-independently soluble in aqueous media at 25 C. Rivaroxaban is only slightly soluble in organic solvents ( acetone, polyethylene glycol 400). Xarelto 10 mg 1 film-coated tablet contains 10 mg rivaroxaban. Each 10 mg film-coated tablet contains mg lactose monohydrate (= mg lactose) per tablet. For a full list of excipient(s) see section Xarelto 15 mg 1 film-coated tablet contains 15 mg rivaroxaban.
171211 Xarelto DS Page 1 of 35 DATA SHEET 1. PRODUCT NAME® (strength pharmaceutical form) Xarelto 10 mg film-coated tablets Xarelto 15 mg film-coated tablets . Xarelto 20 mg film-coated tablets
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Argatroban for anticoagulation in continuous renal, Continuous Renal Replacement, Citrate Practicall Issues, Anticoagulation, Continuous Renal Replacement Therapy, CRRT Care and Maintenance, CRRT) Care and Maintenance, Slow, low, efficient, daily dialysis SLEDD, Renal replacement, PRACTICE GUIDELINES FOR ANTICOAGULATION, PRACTICE GUIDELINES FOR ANTICOAGULATION MANAGEMENT, Pocket Reference for ICU Staff, DOSING & MANAGEMENT GUIDE